OWD
IDXX icon

Osborn Williams & Donohoe’s Idexx Laboratories IDXX Stock Holding History

Osborn Williams & Donohoe’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-400
Closed -$90K – 470
2019
Q1 		$90K Buy
+400
New +$82.6K 0.01% 423

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Osborn Williams & Donohoe's IDXX Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Idexx Laboratories (IDXX) in Q2 2019, closing a stake of 400 shares — an estimated $90K sold.

Osborn Williams & Donohoe first reported a position in IDXX in Q1 2019 and held it in 1 quarter. The position peaked at $90K in Q1 2019. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.

  • Osborn Williams & Donohoe reported no remaining Idexx Laboratories position as of Q2 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 400 Idexx Laboratories shares in Q2 2019, an estimated $90K.
  • Osborn Williams & Donohoe first reported a position in Idexx Laboratories in Q1 2019 and held it in 1 quarter.
  • Osborn Williams & Donohoe's Idexx Laboratories position peaked at $90K in Q1 2019.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.